List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 369 studies with search of: Open Studies | "Esophageal Diseases"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Esophageal Cancer Risk Registry
Conditions: Esophageal Cancer;   Gastroesophageal Reflux Disease;   Esophageal Diseases;   Hiatal Hernia;   Esophageal Achalasia
Interventions: Procedure: Survey of client health, personal habits, family history;   Procedure: Blood specimen for non-DNA and DNA parts;   Procedure: Biopsy of esophageal/stomach tissue, lymph nodes, tumor;   Procedure: Biopsies from routine clinical surveillance endoscopies
2 Recruiting Evaluation of Topical Mitomycin C as Adjuvant Drug to Esophageal Dilation in Children
Conditions: Esophageal Stricture;   Caustic Esophageal Stricture;   Peptic Esophageal Stricture;   Post-Surgical Esophageal Stricture
Intervention: Drug: Mitomycin C
3 Recruiting Quality of Life With Esophageal Stent Trial
Conditions: Esophageal Cancer;   Gastro-esophageal Junction Cancer
Interventions: Behavioral: Home visits;   Behavioral: standard
4 Recruiting Identifying Genetic Markers for Esophageal Cancer and Stomach Cancer in Chinese Populations
Conditions: Esophageal Cancer;   Gastric Cancer
Interventions: Genetic: DNA analysis;   Genetic: genetic linkage analysis;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: study of high risk factors
5 Recruiting Genetic and Environmental Risk Factors Related to Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Genetic: DNA analysis;   Genetic: polymorphism analysis;   Other: questionnaire administration
6 Recruiting Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer;   Gastric Cancer
Interventions: Genetic: DNA analysis;   Genetic: RNA analysis;   Genetic: microarray analysis;   Genetic: protein analysis;   Other: cytology specimen collection procedure;   Other: laboratory biomarker analysis;   Other: questionnaire administration
7 Recruiting Study of Patients With Non-Small Cell Lung Cancer, Esophageal Cancer, Malignant Pleural Mesothelioma, Mediastinal or Chest Wall Neoplasms, or Lung Metastases From Cancers of Non-Thoracic Origin
Conditions: Esophageal Cancer;   Lung Cancer;   Malignant Mesothelioma;   Metastatic Cancer
Interventions: Genetic: DNA methylation analysis;   Genetic: gene expression analysis;   Procedure: bronchoscopy;   Procedure: endoscopic biopsy;   Procedure: needle biopsy
8 Recruiting Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: erlotinib hydrochloride;   Other: immunohistochemistry staining method;   Radiation: radiation therapy
9 Recruiting LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib
Conditions: ErbB2 (HER2) Amplified Gastric;   Esophageal;   or Gastro-esophageal Junction Adenocarcinoma That is Unresectable Due to Locally Advanced Metastatic, or Locally Recurrent Disease.
Intervention: Drug: Lapatinib
10 Recruiting Efficacy and Safety of OncoGel™ Added to Chemotherapy and Radiation Before Surgery in Subjects With Esophageal Cancer
Conditions: Esophageal Cancer;   Adenocarcinoma of the Esophagus;   Squamous Cell Carcinoma
Interventions: Drug: OncoGel (Paclitaxel gel);   Drug: cisplatin;   Drug: 5-FU;   Radiation: radiation therapy;   Procedure: esophageal resection
11 Recruiting Sunitinib in Treating Patients With Relapsed or Refractory Esophageal or Gastroesophageal Junction Cancer
Condition: Esophageal Cancer
Interventions: Drug: sunitinib malate;   Genetic: TdT-mediated dUTP nick end labeling assay;   Other: immunoenzyme technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: computed tomography;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: positron emission tomography
12 Recruiting Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Biological: bevacizumab;   Drug: cisplatin;   Drug: irinotecan hydrochloride;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
13 Recruiting Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Drug: capecitabine;   Drug: oxaliplatin;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Procedure: adjuvant therapy;   Procedure: biopsy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
14 Recruiting Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer
Condition: Esophageal Neoplasms
Intervention: Drug: Capecitabine (Xeloda)
15 Recruiting Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Condition: Esophageal Cancer
Interventions: Biological: cetuximab;   Drug: cisplatin;   Drug: paclitaxel;   Radiation: radiation therapy
16 Recruiting S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery
Condition: Esophageal Cancer
Interventions: Drug: S-1;   Drug: cisplatin;   Other: cytology specimen collection procedure;   Procedure: endoscopic biopsy
17 Recruiting Radiation Therapy and Combination Chemotherapy as First-Line Therapy in Treating Patients With Esophageal Cancer That Cannot Be Removed by Surgery
Condition: Esophageal Cancer
Interventions: Drug: FOLFOX regimen;   Drug: cisplatin;   Drug: fluorouracil;   Drug: leucovorin calcium;   Drug: oxaliplatin;   Procedure: quality-of-life assessment;   Radiation: radiation therapy
18 Recruiting Epirubicin, Oxaliplatin, and Capecitabine or Docetaxel and Oxaliplatin in Treating Patients With Advanced Esophageal Cancer, Gastroesophageal Junction Cancer, or Stomach Cancer
Conditions: Adenocarcinoma of the Gastroesophageal Junction;   Esophageal Cancer;   Gastric Cancer
Interventions: Drug: capecitabine;   Drug: docetaxel;   Drug: epirubicin hydrochloride;   Drug: oxaliplatin
19 Recruiting Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer
Conditions: Gastric Cancer;   Esophageal Cancer
Intervention: Drug: Docetaxel, Cisplatin, Capecitabine
20 Recruiting A Pilot for a Case-Control Study of Esophageal Squamous Cell Carcinoma in Western Kenya
Condition: Esophageal Neoplasms
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services